Conmed to acquire orthopedic devicemaker for up to $250M

Alan Condon -  

Conmed Corp. on Aug. 1 announced a definitive agreement to acquire Biorez, a startup focused on advancing the healing of soft tissue using its BioBrace implant technology.

The acquisition would include $85 million at closing and up to an additional $165 million in growth-based earnout payments over the next four years, Conmed said in a news release. 

The BioBrace implant is an FDA-cleared bioinductive scaffold designed to reinforce soft tissue where weakness exists and facilitate healing, according to Biorez. 

The transaction is expected to close this month.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers